Product Information
RIFAMPIN 300 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.6891 per EA under NDC 00904731561. Its NADAC has been published 53 times since Jun 25, 2025.
Strength
300 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904731561
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA090034On Market Since
2/25/2025
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 300 MG CAPSULE has been published 53 times since Jun 25, 2025, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6891 per EA |
|---|---|
| All-time high | $0.7246 (Jul 16, 2025) |
| All-time low | $0.6805 (Apr 22, 2026) |
| 52-week high | $0.7246 |
| 52-week low | $0.6805 |
| Median price | $0.6952 |
| Average price | $0.7000 |
| Largest weekly change | -2.3% (Nov 19, 2025) |
| Weeks tracked | 53 |
| Tracking since | Jun 25, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIFAMPIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 300 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.6891 per EA (NDC 00904731561), effective Jun 24, 2026.
How has the price of RIFAMPIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 300 MG CAPSULE has declined 4.9%. It has been tracked across 53 weekly CMS publications since Jun 25, 2025.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 300 MG CAPSULE?
Since Jun 25, 2025, the NADAC for RIFAMPIN 300 MG CAPSULE has ranged from a low of $0.6805 (Apr 22, 2026) to a high of $0.7246 (Jul 16, 2025), with a median of $0.6952 per EA.
Are there cheaper alternatives to RIFAMPIN 300 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as RIFAMPIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures RIFAMPIN 300 MG CAPSULE?
RIFAMPIN 300 MG CAPSULE (NDC 00904731561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification